Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on June 17, 2026

Jun. 17, 2026

Nyxoah Reçoit 15 Millions de Dollars de la Banque Européenne d’Investissement

Indeterminate GlobeNewswire

Jun. 17, 2026

Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia

Indeterminate GlobeNewswire

Jun. 17, 2026

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 17, 2026

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States

Indeterminate GlobeNewswire

Jun. 17, 2026

PruittHealth Expands Home Health Presence in South Georgia

Indeterminate GlobeNewswire

Jun. 17, 2026

Ontario Shores partners with community organizations to bring dementia care training to families

Indeterminate GlobeNewswire

Jun. 17, 2026

Nova Southeastern University Opens Nevada Campus to Address Growing Need for Healthcare Professionals in the Region

Indeterminate GlobeNewswire

Jun. 17, 2026

Banner Health welcomes new executive to grow access, value-based care across multi-state system

Indeterminate GlobeNewswire

Jun. 17, 2026

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

Indeterminate GlobeNewswire

Jun. 17, 2026

AB Science patent for masitinib in the treatment of metastatic castrate resistant prostate cancer formally granted in the United States with a protection until 2042

Indeterminate GlobeNewswire

Jun. 17, 2026

Le brevet d’AB Science concernant le masitinib dans le traitement du cancer de la prostate métastatique hormono-résistant a été officiellement délivré aux Etats-Unis avec une durée de protection jusqu’en 2042

Indeterminate GlobeNewswire

Jun. 17, 2026

RESTEM to Present at BIO International Convention

Indeterminate GlobeNewswire

Jun. 17, 2026

Applied Biologics Announces Completion of Planned Enrollment Activities in the CAMPX Randomized Controlled Trial Evaluating XWRAP®

Indeterminate GlobeNewswire

Jun. 17, 2026

CTD-ILD Enters New Treatment Era, but Physicians Still See Significant Unmet Need

Indeterminate GlobeNewswire

Jun. 17, 2026

AFTD Welcomes Rachel Biblow as New Chief Executive Officer

Indeterminate GlobeNewswire

Jun. 17, 2026

NASM Rewrites the Rules of Training for Clients Using GLP-1 Weight Loss Medications

Indeterminate GlobeNewswire

Jun. 17, 2026

AI Disruption in Dermatology Devices Accelerates with $43 Million Series B Funding Wave, Driven by 96% Diagnostic Accuracy Breakthrough

Indeterminate GlobeNewswire

Jun. 17, 2026

Knock Out Opioid Abuse Day Webinar to Address Shifting Disparities in Opioid Overdose Prevention

Indeterminate GlobeNewswire

Jun. 17, 2026

MedX Holdings Accelerates Growth: Expanding Lazydaze Franchise Footprint, Unveiling Major Product Innovations, and Strengthening Brand Infrastructure

Indeterminate GlobeNewswire

Jun. 17, 2026

Octane Launches Mussallem Cardiovascular Accelerator to Advance Next Generation of Heart Health Innovation

Indeterminate GlobeNewswire